US Patent Issued to The Governors of the University of Alberta on May 13 for "Hepatitis C virus immunogenic compositions and methods of use thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,005, issued on May 13, was assigned to The Governors of the University of Alberta (Edmonton, Canada).

"Hepatitis C virus immunogenic compositions and methods of use thereof" was invented by Michael Houghton (Danville, Calif.), Abdolamir Landi (Edmonton, Canada), Michael Logan (Edmonton, Canada), John L. Law (Edmonton, Canada), Darren Hockman (Edmonton, Canada) and Chao Chen (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides an immunogenic composition comprising: a) a hepatitis C virus (HCV) heterodimeric polypeptide that includes HCV E1 and E2 polypeptides; b) a T-cell epitope polypeptide comprising a T-...